E
INSM icon

Ergoteles’s Insmed INSM Stock Holding History

Ergoteles’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-77,184
Closed -$1.32M – 1252
2023
Q1 		$1.32M Buy
+77,184
New +$1.5M 0.05% 395
2022
Q4 		– Sell
-115,121
Closed -$2.48M – 1659
2022
Q3 		$2.48M Buy
115,121
+91,996
+398% +$2.21M 0.09% 227
2022
Q2 		$456K Sell
23,125
-9,737
-30% -$204K 0.01% 878
2022
Q1 		$772K Buy
+32,862
New +$764K 0.03% 517
2021
Q3 		– Sell
-8,100
Closed -$231K – 1430
2021
Q2 		$231K Buy
+8,100
New +$240K 0.01% 1204

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ergoteles's INSM Position: Q2 2023 in Review

Ergoteles sold out of Insmed (INSM) in Q2 2023, closing a stake of 77,184 shares — an estimated $1.32M sold.

Ergoteles first reported a position in INSM in Q2 2021 and held it in 5 quarters. The position peaked at $2.48M in Q3 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

  • Ergoteles reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 77,184 Insmed shares in Q2 2023, an estimated $1.32M.
  • Ergoteles first reported a position in Insmed in Q2 2021 and held it in 5 quarters.
  • Ergoteles's Insmed position peaked at $2.48M in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.